{name}
{subtitle}
Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
city
~67 mi. (Ufa, Russia, +176 more cities)
facility
Republican Clinical Oncology Dispensary of Republic of Bashkortostan ( Site 2645)
condition
Endometrial Carcinoma, +1 more condition
drug
chemotherapy, +2 more drugs
drug type
chemotherapy, +2 more types
Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)
city
~67 mi. (Ufa, Russia, +159 more cities)
facility
Clinic of Bashkortostan State Medical University ( Site 0869)
drug
cisplatin, +2 more drugs
drug type
chemotherapy, +1 more type
Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Cisplatin-ineligible Participants With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)
city
~67 mi. (Ufa, Russia, +163 more cities)
facility
Clinic of Bashkortostan State Medical University ( Site 0873)
drug
cystectomy, +2 more drugs
drug type
chemotherapy, +3 more types
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014)
city
~67 mi. (Ufa, Russia, +45 more cities)
facility
Republican Clinical Oncology Dispensary of Republic of Bashkortostan ( Site 1507)
drug
cisplatin, +5 more drugs
drug type
chemotherapy, +2 more types
Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)
city
~67 mi. (Ufa, Russia, +137 more cities)
facility
GBUZ Republican Clinical Oncological Dispensary-Antitumor drug therapy department ( Site 1171)
Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)
city
~67 mi. (Ufa, Russia, +126 more cities)
facility
GBUZ Republican Clinical Oncological Dispensary-Antitumor drug therapy department ( Site 0430)
drug
FOLFOX regimen, +3 more drugs
drug type
chemotherapy, +2 more types
Efficacy and Safety of Olaparib (MK-7339) With or Without Bevacizumab Compared to Bevacizumab With a Fluoropyrimidine in Unresectable or Metastatic Colorectal Cancer (CRC) (MK-7339-003/LYNK-003)
city
~67 mi. (Ufa, Russia, +105 more cities)
facility
GBUZ Republican Clinical Oncological Dispensary-Antitumor drug therapy department ( Site 1130)
drug
bevacizumab, +1 more drug
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL) or Pancreatic Neuroendocrine Tumor (pNET) (MK-6482-015)
city
~67 mi. (Ufa, Russia, +29 more cities)
facility
GBUZ Republican Clinical Oncological Dispensary ( Site 0804)
condition
Pancreatic Neuroendocrine Tumor, +1 more condition